Previous close | 0.1100 |
Open | 0.1100 |
Bid | 0.0400 |
Ask | 0.1100 |
Strike | 72.50 |
Expiry date | 2025-01-17 |
Day's range | 0.1100 - 0.1100 |
Contract range | N/A |
Volume | |
Open interest | 903 |
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
PRINCETON, N.J., May 07, 2024--Bristol Myers Squibb to Participate in Upcoming Investor Conferences
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)